tiprankstipranks
Wuxi Biologics (Cayman) Inc. (WXIBF)
OTHER OTC:WXIBF

Wuxi Biologics (Cayman) (WXIBF) Cash flow

118 Followers

Wuxi Biologics (Cayman) Cash Flow

WXIBF's free cash flow for Q2 2022 was ¥―. For the 2022 fiscal year, WXIBF's free cash flow was decreased by ¥1.05B and operating cash flow was ¥―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
-¥ 3.43B¥ 1.88B¥ 1.21B¥ 761.61M¥ 360.28M
Investing Cash Flow
-¥ -9.60B¥ -7.22B¥ -4.49B¥ -416.07M¥ -2.21B
Financing Cash Flow
-¥ 8.21B¥ 6.57B¥ 5.41B¥ 3.21B¥ 2.23B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-¥ 9.00B¥ 7.10B¥ 6.21B¥ 4.08B¥ 503.88M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-¥ 11.04B¥ 5.65B¥ 3.60B¥ 3.23B¥ 3.57B
Issuance Of Debt
-¥ 675.28M¥ 1.17B¥ 2.05B¥ 0.00¥ 401.61M
Repayment Of Debt
-¥ -728.27M¥ -300.78M¥ -140.00M¥ 0.00¥ -1.48B
Free Cash Flow
-¥ -3.09B¥ -4.14B¥ -2.03B¥ -1.07B¥ -327.45M
Domestic Sales
------
Foreign Sales
------
Currency in CNY

Wuxi Biologics (Cayman) Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis